Pembrolizumab in relapsed or refractory Richter syndrome.

BRITISH JOURNAL OF HAEMATOLOGY(2020)

Cited 28|Views0
No score
Key words
chronic lymphocytic leukaemia,immunotherapy,PD-1,pembrolizumab,Richter syndrome
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined